Overview
- 131 inspections across 115 sites are on record.
- 194 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-12-12.
At a glance
Inspections
131
Sites
115
Observations
194
Career since
Nov 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Jeffrey M. Miller, M.D. | 12 Dec 2023 | Human Drugs | |
| Pragma Pharmaceuticals Llc | 11 Mar 2020 | Human Drugs | |
| Emily Slotkin, MD | 19 Feb 2020 | Biologics | |
| George Stoica MD | 30 Jan 2020 | Human Drugs | |
| Regeneron Pharmaceuticals Inc | 17 Jan 2020 | Human Drugs |
Sites inspected
Jeffrey M. Miller, M.D.New York, United States1 insp.
Pragma Pharmaceuticals LlcLocust Valley, United States1 insp.
Emily Slotkin, MDNew York, United States1 insp.
George Stoica MDOrlando, United States1 insp.
Regeneron Pharmaceuticals IncTarrytown, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Joy P Matthias4 shared
Omadevi Somai3 shared
Matthew R Palo3 shared
Stephanie Durso3 shared
Frank Verni3 shared
Tara K Carmody2 shared
Kerun Hardeo1 shared
Michael F Skelly1 shared
Melkamu Getie Kebtie1 shared
John B Crowe1 shared
Full investigator report
Get the verbatim findings behind Iram R Hassan's 194 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site